COVID-19 remains a concern in several regions, with the JN.1 variant, a descendant of the Omicron BA.2.86 lineage, being the ...

What sets JN.1 apart is a unique mutation in the spike protein — the part of the virus that binds to human cells. This ...

COVID-19 Is Back! The JN.1 variant is spreading rapidly across Asia: How COVID vaccines have prevented the past variants and ...

A fresh wave of Covid-19 has been reported across Asia including countries like Singapore, Hong Kong, China and Thailand.

US researchers have engineered a novel gene therapy to target the airway and lungs via a nasal spray. For gene therapy to ...

JN.1 was first detected in the US in August 2023 and classified by the WHO as a Variant of Interest by December that year. It ...

Kerala reports 182 Covid-19 cases in May, prompting increased testing, hospital precautions, and mask mandates. Health ...

Researchers demonstrated that specific electromagnetic wave frequencies can disrupt the SARS-CoV-2 Spike protein structure in ...

Kerala Health Minister Veena George has confirmed 182 COVID-19 cases reported in May so far, with Kottayam district logging ...

GeoVax’s Advanced MVA Manufacturing Platform Supports ASPR-DARPA Vision for Scalable, AI-Integrated Pharmaceutical Production. ATLANTA, GA - May 21, 2025 (NEWMEDIAWIRE) - GeoVax ...

Adar Poonawalla-led Serum Institute of India was the poster child of the fight against Covid-19 with Covishield. it is now ...

2025 — Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic ...